Chuandong Zhu

5PUBLICATIONS
11CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 11, 2026
The E3 ubiquitin ligase RNF180 modulates the EGFR/PI3K/AKT pathway to reduce cisplatin resistance in non-small cell lung cancer.

Xiaoyan Song, Wen Jiang, Hongxuan Wei

|Nov 27, 2025
hsa_circ_0135681 functions as a novel tumor-suppressive circular RNA regulating Glycolysis and EMT to attenuate cisplatin resistance in non-small cell lung cancer.

Xiaoyan Song, Huihui Li, Yan Zhu

|Jul 05, 2024
MiR-135b-5p promotes cetuximab resistance in colorectal cancer by regulating FOXN3.

Chun Peng, Xiaoqing Li, Yuhui Yao

|Mar 17, 2021
Circulating Exosomal miR-96 as a Novel Biomarker for Radioresistant Non-Small-Cell Lung Cancer.

Qin Zheng, Huaiyin Ding, Lixue Wang

|Aug 01, 2020
CT-Guided Percutaneous Microwave Ablation of Sclerosing Hepatic Carcinoma.

Hongshen Song, Huaiyin Ding, Chuandong Zhu

Pageof 1

Frequent Collaborators

2 joint publications

Xiaoyan Song

2 joint publications

Yan Zhu

2 joint publications

Hongxuan Wei

2 joint publications

Fangfang Chen